Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia
Clinical trial NCT00528450 · TERMINATED
Trial details
- NCT number
- NCT00528450
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2011-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.